查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1699379

軟組織修復市場機會、成長動力、產業趨勢分析及 2025-2034 年預測

Soft Tissue Repair Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球軟組織修復市場規模達到 144 億美元，預計 2025 年至 2034 年期間的複合年成長率為 5.1%。運動傷害、創傷病例和與年齡相關的軟組織損傷的增加正在推動對手術解決方案的需求。老年人口的成長和肥胖率的上升導致疝氣和其他需要軟組織修復的疾病的發生率上升。生物相容性產品和合成網片解決方案的進步正在改善患者的治療效果，使手術介入更加有效。影像技術和微創手術的進步縮短了恢復時間並減少了術後併發症。

軟組織修復市場 - IMG1

人們對創新修復技術的認知不斷提高以及患者治療效果的改善推動了市場的成長。運動醫學的擴展和青少年體育運動參與度的提高導致受傷率上升，進一步推動了需求。此外，新興市場政府對醫療保健的投資正在創造新的成長機會。再生醫學的未來發展，包括富含血小板血漿 (PRP) 療法和幹細胞治療，有望徹底改變該領域。醫療支出的增加和複雜手術的保險覆蓋範圍的擴大提高了人們獲得先進修復方法的機會。門診手術中心向門診服務的轉變凸顯了成本效益高、便利的照護趨勢，增強了市場擴張。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 144億美元
預測值 243億美元
複合年成長率 5.1%

軟組織修復包括肌肉修復、筋膜縫合以及韌帶、肌腱和皮膚組織損傷的治療。這包括圍手術期和術後干涉，例如非手術縫合、生物解決方案和旨在緩解疼痛和恢復運動的再生幹細胞療法。市場分為組織貼片/基質和組織固定裝置。組織補片/基質領域受手術對有效支架解決方案的需求推動，預計年複合成長率為 4.9%，到 2034 年將達到 157 億美元以上。創傷、疝氣和與年齡相關的組織退化病例的增加正在推動需求。材料科學的進步，特別是生物工程和合成貼片，由於具有優異的生物相容性和較低的排斥風險，改善了患者的治療效果。

現代外科手術技術，例如腹腔鏡手術，透過減少併發症和恢復期來支持組織貼片的採用。運動傷害發生率的上升和人口老化的加劇進一步要求有效的組織修復解決方案。再生醫學的創新，包括與天然組織無縫結合的生物工程支架，擴大了其應用範圍。醫療保健投資的增加和外科手術保險覆蓋範圍的擴大促進了先進組織修復解決方案的更廣泛應用。門診手術中心對門診手術的關注加速了對具有成本效益和快速恢復材料的需求，使組織基質和貼片成為外科醫生的首選。

市場按應用細分為疝氣修復、整形外科手術、皮膚修復、硬膜修復和其他治療。受肥胖率上升、人口老化和久坐不動的生活方式的影響，疝氣修復手術將在 2024 年佔據 34.7% 的市場佔有率。腹腔鏡和開放式手術的普及推動了對先進修復材料的需求，包括減少復發和縮短恢復時間的合成和生物網片。患者和外科醫生對疝氣修復解決方案的信心增強，並繼續推動市場擴張。

最終用途細分包括醫院、門診手術中心和診所。 2024 年，醫院佔據市場主導地位，佔有 48.3% 的佔有率，預計到 2034 年將達到 121 億美元。大量複雜的外科手術病例、先進的醫療基礎設施和專業的術後護理使醫院成為主要的治療中心。由於人口老化和生活方式相關因素導致的手術量不斷增加，進一步鞏固了醫院在軟組織修復領域的主導地位。

美國軟組織修復市場價值在 2023 年為 47 億美元，2024 年為 51 億美元，預計成長強勁。慢性病、運動傷害和與年齡相關的組織退化病例的增加推動了對先進修復解決方案的需求。生物製劑和合成網片的日益普及提高了治療的效果。微創腹腔鏡技術可縮短恢復時間並減少併發症，越來越受到人們的關注。優惠的報銷政策和高額的醫療支出使更多患者能夠獲得創新的修復方法。領先製造商的存在促進了產品的持續開發，並增強了市場的成長。向門診手術中心和先進醫院基礎設施的轉變支持更廣泛的

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 肥胖人口不斷增加
      • 運動傷害發生率不斷上升
      • 軟組織修復手術的最新進展
      • 骨科疾病盛行率不斷上升
    • 產業陷阱與挑戰
      • 軟組織修復手術費用過高
      • 嚴格的監管框架
  • 成長潛力分析
  • 監管格局
  • 技術格局
  • 差距分析
  • 波特的分析
  • PESTEL分析
  • 價值鏈分析

第4章：競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第5章：市場估計與預測：按產品，2021 年至 2034 年

  • 主要趨勢
  • 組織貼片/基質
    • 合成網
    • 生物網片
      • 同種異體移植
      • 異種移植
  • 組織固定裝置
    • 縫合錨
    • 縫合線
    • 過盈螺絲
    • 其他組織固定裝置

第6章：市場估計與預測：按應用，2021 年至 2034 年

  • 主要趨勢
  • 疝氣修補術
  • 骨科
  • 皮膚修復
  • 硬腦膜修復
  • 其他應用

第7章：市場估計與預測：依最終用途，2021 年至 2034 年

  • 主要趨勢
  • 醫院
  • 門診手術中心
  • 診所

第8章：市場估計與預測：按地區，2021 年至 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章：公司簡介

  • Anika Therapeutics
  • Arthrex
  • Baxter
  • Becton, Dickinson and Company
  • Collagen Matrix
  • CONMED
  • CryoLife
  • Depuy Synthes (Johnson & Johnson)
  • Integra LifeSciences
  • Medprin
  • Medtronic
  • Smith & Nephew
  • Stryker Corporation
  • Zimmer Biomet
簡介目錄
Product Code: 4166

The Global Soft Tissue Repair Market reached USD 14.4 billion in 2024 and is projected to expand at a CAGR of 5.1% from 2025 to 2034. Rising sports injuries, trauma cases, and age-related soft tissue damage are driving demand for surgical solutions. A growing elderly population and increasing obesity rates contribute to higher incidences of hernias and other conditions requiring soft tissue repair. Advances in biocompatible products and synthetic mesh solutions are improving patient outcomes, making surgical interventions more effective. Progress in imaging techniques and minimally invasive procedures enhances recovery times and reduces post-operative complications.

Soft Tissue Repair Market - IMG1

Greater awareness of innovative repair techniques and improved patient outcomes fuel market growth. The expansion of sports medicine and increased youth participation in sports result in higher injury rates, further driving demand. Additionally, government investments in healthcare in emerging markets are creating new growth opportunities. Future developments in regenerative medicine, including platelet-rich plasma (PRP) therapy and stem cell treatments, are expected to revolutionize the field. Increased healthcare spending and insurance coverage for complex surgeries improve access to advanced repair methods. A shift towards outpatient services in ambulatory surgical centers highlights the trend of cost-effective, convenient care, reinforcing market expansion.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$14.4 Billion
Forecast Value$24.3 Billion
CAGR5.1%

Soft tissue repair encompasses muscle restoration, fascia suturing, and treatment of ligaments, tendons, and skin tissue damage. This includes perioperative and post-operative interventions such as non-surgical sutures, biological solutions, and regenerative stem cell therapies aimed at pain relief and motion recovery. The market is divided into tissue patch/matrix and tissue fixation devices. The tissue patch/matrix segment, driven by the need for effective scaffolding solutions in surgeries, is expected to grow at a CAGR of 4.9%, reaching over USD 15.7 billion by 2034. Increased cases of traumatic injuries, hernias, and age-related tissue degeneration are boosting demand. Advances in materials science, particularly bioengineered and synthetic patches, enhance patient outcomes due to superior biocompatibility and lower rejection risks.

Modern surgical techniques, such as laparoscopic procedures, support the adoption of tissue patches by reducing complications and recovery periods. The rising incidence of sports injuries and a growing aging population further necessitate efficient tissue repair solutions. Innovations in regenerative medicine, including bioengineered scaffolds that integrate seamlessly with native tissues, expand their applications. Increased healthcare investments and improved insurance coverage for surgical procedures facilitate wider adoption of advanced tissue repair solutions. The focus on outpatient procedures in ambulatory surgical centers accelerates the demand for cost-effective and rapid recovery materials, positioning tissue matrices and patches as preferred options among surgeons.

The market is segmented by application into hernia repair, orthopedic procedures, skin repair, dural repair, and other treatments. Hernia repair accounted for 34.7% of the market in 2024, driven by rising obesity rates, an aging population, and sedentary lifestyles. Increased adoption of laparoscopic and open surgical procedures boosts demand for advanced repair materials, including synthetic and biological meshes that reduce recurrence and improve recovery times. Enhanced patient and surgeon confidence in hernia repair solutions continues to drive market expansion.

End-use segmentation includes hospitals, ambulatory surgical centers, and clinics. Hospitals led the market in 2024, holding a 48.3% share and projected to reach USD 12.1 billion by 2034. The high volume of complex surgical cases, advanced medical infrastructure, and specialized post-operative care make hospitals the primary treatment centers. Rising surgical volumes due to aging populations and lifestyle-related conditions further reinforce hospital dominance in soft tissue repair.

The U.S. soft tissue repair market was valued at USD 4.7 billion in 2023 and USD 5.1 billion in 2024, with strong growth projections. Increased cases of chronic diseases, sports injuries, and age-related tissue degeneration drive demand for advanced repair solutions. The growing adoption of biologics and synthetic meshes enhances the effectiveness of treatments. Minimally invasive laparoscopic techniques, which shorten recovery times and reduce complications, are gaining traction. Favorable reimbursement policies and high healthcare spending enable greater patient access to innovative repair methods. The presence of leading manufacturers fosters continuous product development, strengthening market growth. The shift toward outpatient surgical centers and advanced hospital infrastructure supports broader ado

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising obese population
      • 3.2.1.2 Increasing incidence of sports injuries
      • 3.2.1.3 Recent advancements in soft tissue repair procedures
      • 3.2.1.4 Increasing prevalence of orthopedic conditions
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Excessive cost of soft tissue repair procedures
      • 3.2.2.2 Stringent regulatory framework
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Gap analysis
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Value chain analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Tissue patch/Matrix
    • 5.2.1 Synthetic mesh
    • 5.2.2 Biologic mesh
      • 5.2.2.1 Allograft
      • 5.2.2.2 Xenograft
  • 5.3 Tissue fixation devices
    • 5.3.1 Suture anchors
    • 5.3.2 Sutures
    • 5.3.3 Interference screws
    • 5.3.4 Other tissue fixation devices

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hernia repair
  • 6.3 Orthopedic
  • 6.4 Skin repair
  • 6.5 Dural repair
  • 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Clinics

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Anika Therapeutics
  • 9.2 Arthrex
  • 9.3 Baxter
  • 9.4 Becton, Dickinson and Company
  • 9.5 Collagen Matrix
  • 9.6 CONMED
  • 9.7 CryoLife
  • 9.8 Depuy Synthes (Johnson & Johnson)
  • 9.9 Integra LifeSciences
  • 9.10 Medprin
  • 9.11 Medtronic
  • 9.12 Smith & Nephew
  • 9.13 Stryker Corporation
  • 9.14 Zimmer Biomet